Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
beta-Glucans | 19 | 2021 | 43 | 3.140 |
Why?
|
Glucans | 18 | 2019 | 49 | 2.150 |
Why?
|
Saccharomyces cerevisiae | 14 | 2022 | 526 | 1.880 |
Why?
|
Terpenes | 2 | 2022 | 20 | 1.820 |
Why?
|
Fungal Vaccines | 10 | 2020 | 38 | 1.630 |
Why?
|
Anthelmintics | 5 | 2021 | 38 | 1.460 |
Why?
|
Adjuvants, Immunologic | 10 | 2021 | 221 | 1.460 |
Why?
|
Nematoda | 3 | 2021 | 33 | 1.260 |
Why?
|
Humic Substances | 2 | 2021 | 3 | 0.990 |
Why?
|
Aflatoxin B1 | 2 | 2021 | 6 | 0.990 |
Why?
|
Disinfectants | 1 | 2022 | 18 | 0.960 |
Why?
|
Vaccines | 5 | 2020 | 75 | 0.960 |
Why?
|
Nanoparticles | 6 | 2021 | 424 | 0.950 |
Why?
|
Antigens, Fungal | 6 | 2019 | 44 | 0.890 |
Why?
|
Cell Wall | 5 | 2021 | 112 | 0.870 |
Why?
|
Coccidioides | 5 | 2020 | 10 | 0.860 |
Why?
|
Coccidioidomycosis | 5 | 2020 | 9 | 0.860 |
Why?
|
Nematode Infections | 1 | 2020 | 35 | 0.850 |
Why?
|
Vaccination | 8 | 2019 | 233 | 0.670 |
Why?
|
Animals | 46 | 2021 | 17863 | 0.640 |
Why?
|
Cryptococcosis | 3 | 2019 | 55 | 0.520 |
Why?
|
Mice | 30 | 2021 | 9049 | 0.510 |
Why?
|
Ovalbumin | 6 | 2017 | 114 | 0.500 |
Why?
|
Lectins, C-Type | 4 | 2020 | 78 | 0.490 |
Why?
|
Cryptococcus neoformans | 3 | 2019 | 124 | 0.490 |
Why?
|
Fungi | 3 | 2020 | 43 | 0.450 |
Why?
|
Mice, Inbred C57BL | 19 | 2021 | 2921 | 0.420 |
Why?
|
Chitin | 5 | 2019 | 38 | 0.420 |
Why?
|
Macrophages | 8 | 2020 | 942 | 0.410 |
Why?
|
Ascomycota | 2 | 2015 | 10 | 0.410 |
Why?
|
Hookworm Infections | 2 | 2021 | 14 | 0.410 |
Why?
|
Ancylostomatoidea | 2 | 2020 | 11 | 0.400 |
Why?
|
Gene Transfer Techniques | 2 | 2011 | 262 | 0.400 |
Why?
|
Huntingtin Protein | 3 | 2020 | 124 | 0.390 |
Why?
|
Tularemia | 2 | 2019 | 15 | 0.390 |
Why?
|
Francisella tularensis | 2 | 2019 | 21 | 0.390 |
Why?
|
Th17 Cells | 5 | 2021 | 42 | 0.380 |
Why?
|
Drug Delivery Systems | 5 | 2019 | 265 | 0.370 |
Why?
|
Hemolysin Proteins | 2 | 2019 | 41 | 0.370 |
Why?
|
Endotoxins | 2 | 2019 | 73 | 0.370 |
Why?
|
Bacterial Vaccines | 2 | 2019 | 80 | 0.360 |
Why?
|
Antigens | 3 | 2020 | 147 | 0.350 |
Why?
|
Dendritic Cells | 5 | 2015 | 495 | 0.340 |
Why?
|
Cryptococcus gattii | 2 | 2017 | 10 | 0.330 |
Why?
|
DNA | 2 | 2008 | 696 | 0.310 |
Why?
|
Ancylostoma | 3 | 2020 | 20 | 0.300 |
Why?
|
Bacterial Proteins | 3 | 2021 | 710 | 0.290 |
Why?
|
Peyer's Patches | 2 | 2015 | 33 | 0.290 |
Why?
|
Huntington Disease | 2 | 2017 | 128 | 0.270 |
Why?
|
Albendazole | 2 | 2020 | 9 | 0.270 |
Why?
|
Yeasts | 2 | 2018 | 55 | 0.260 |
Why?
|
Drug Carriers | 2 | 2017 | 152 | 0.260 |
Why?
|
Anthrax | 1 | 2003 | 14 | 0.260 |
Why?
|
Proteoglycans | 2 | 2021 | 33 | 0.250 |
Why?
|
Cytokines | 7 | 2020 | 859 | 0.250 |
Why?
|
Mice, Inbred BALB C | 7 | 2019 | 914 | 0.250 |
Why?
|
Fungal Proteins | 3 | 2019 | 159 | 0.240 |
Why?
|
Escherichia coli | 6 | 2019 | 676 | 0.240 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2018 | 599 | 0.240 |
Why?
|
Ancylostomiasis | 2 | 2019 | 13 | 0.240 |
Why?
|
Fungal Polysaccharides | 1 | 2021 | 4 | 0.240 |
Why?
|
Mycoses | 2 | 2020 | 38 | 0.230 |
Why?
|
Anti-Infective Agents | 1 | 2003 | 102 | 0.230 |
Why?
|
Recombinant Proteins | 6 | 2019 | 659 | 0.230 |
Why?
|
Cloning, Molecular | 4 | 2017 | 371 | 0.230 |
Why?
|
Drug Compounding | 1 | 2022 | 72 | 0.230 |
Why?
|
Lung | 7 | 2020 | 597 | 0.230 |
Why?
|
Capsules | 1 | 2021 | 28 | 0.220 |
Why?
|
Parasites | 1 | 2021 | 12 | 0.220 |
Why?
|
Mannans | 2 | 2018 | 17 | 0.220 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 47 | 0.220 |
Why?
|
Sheep Diseases | 1 | 2020 | 6 | 0.220 |
Why?
|
Haemonchus | 1 | 2020 | 8 | 0.220 |
Why?
|
Haemonchiasis | 1 | 2020 | 7 | 0.220 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 109 | 0.220 |
Why?
|
Vaccines, Combined | 1 | 2020 | 2 | 0.210 |
Why?
|
Probiotics | 1 | 2020 | 30 | 0.210 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2020 | 52 | 0.210 |
Why?
|
Benzimidazoles | 1 | 2020 | 49 | 0.200 |
Why?
|
Disease Resistance | 1 | 2020 | 23 | 0.200 |
Why?
|
Host-Pathogen Interactions | 2 | 2020 | 219 | 0.200 |
Why?
|
Strongyloides stercoralis | 1 | 2019 | 9 | 0.200 |
Why?
|
Bacillus subtilis | 3 | 1984 | 26 | 0.200 |
Why?
|
Cysteine Proteases | 1 | 2019 | 3 | 0.200 |
Why?
|
Antigens, Helminth | 1 | 2019 | 23 | 0.200 |
Why?
|
Antibodies, Helminth | 1 | 2019 | 26 | 0.200 |
Why?
|
Zea mays | 1 | 2019 | 22 | 0.200 |
Why?
|
Plasmids | 3 | 1984 | 269 | 0.190 |
Why?
|
Multiple Sclerosis | 1 | 2021 | 164 | 0.190 |
Why?
|
Protozoan Vaccines | 1 | 2018 | 14 | 0.190 |
Why?
|
Antigens, Surface | 2 | 2019 | 189 | 0.190 |
Why?
|
Cell Movement | 2 | 2020 | 397 | 0.190 |
Why?
|
Receptors, CCR2 | 1 | 2018 | 13 | 0.190 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 25 | 0.190 |
Why?
|
Chlorides | 1 | 2018 | 39 | 0.180 |
Why?
|
Histoplasma | 1 | 2018 | 8 | 0.180 |
Why?
|
Ferric Compounds | 1 | 2018 | 42 | 0.180 |
Why?
|
Histoplasmosis | 1 | 2018 | 12 | 0.180 |
Why?
|
Adsorption | 1 | 2018 | 76 | 0.180 |
Why?
|
Bacillus thuringiensis | 1 | 2018 | 14 | 0.180 |
Why?
|
Disease Models, Animal | 6 | 2021 | 1802 | 0.180 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 43 | 0.180 |
Why?
|
Immunity, Cellular | 3 | 2018 | 187 | 0.180 |
Why?
|
Mechanotransduction, Cellular | 1 | 2018 | 30 | 0.180 |
Why?
|
alpha-Synuclein | 1 | 2017 | 16 | 0.180 |
Why?
|
Myeloid Cells | 2 | 2017 | 85 | 0.170 |
Why?
|
Inflammation Mediators | 1 | 2018 | 161 | 0.170 |
Why?
|
Vaccines, Synthetic | 4 | 2019 | 64 | 0.170 |
Why?
|
Lung Diseases, Fungal | 2 | 2017 | 23 | 0.170 |
Why?
|
Hydrodynamics | 1 | 2017 | 24 | 0.170 |
Why?
|
Intestines | 1 | 2018 | 156 | 0.160 |
Why?
|
Immunologic Memory | 1 | 2020 | 331 | 0.160 |
Why?
|
Mutant Proteins | 1 | 2017 | 102 | 0.160 |
Why?
|
Neurodegenerative Diseases | 1 | 2017 | 86 | 0.160 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2020 | 211 | 0.160 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2017 | 171 | 0.160 |
Why?
|
RNA, Small Interfering | 3 | 2014 | 785 | 0.160 |
Why?
|
Monocytes | 1 | 2018 | 337 | 0.160 |
Why?
|
Candida tropicalis | 1 | 2015 | 2 | 0.150 |
Why?
|
Staining and Labeling | 1 | 2017 | 126 | 0.150 |
Why?
|
Trans-Activators | 1 | 2018 | 313 | 0.150 |
Why?
|
Mannose-Binding Lectins | 1 | 2015 | 20 | 0.150 |
Why?
|
Carbohydrates | 2 | 2014 | 37 | 0.150 |
Why?
|
Complement C3 | 3 | 2012 | 61 | 0.150 |
Why?
|
Calnexin | 1 | 2015 | 5 | 0.150 |
Why?
|
Immunity, Humoral | 2 | 2017 | 41 | 0.150 |
Why?
|
Cell Membrane | 1 | 2018 | 473 | 0.150 |
Why?
|
Candida albicans | 1 | 2015 | 51 | 0.150 |
Why?
|
Chitosan | 2 | 2014 | 65 | 0.150 |
Why?
|
Cells, Cultured | 6 | 2020 | 2068 | 0.150 |
Why?
|
Humans | 23 | 2021 | 47720 | 0.150 |
Why?
|
Water | 1 | 2017 | 252 | 0.140 |
Why?
|
Vaccines, Subunit | 3 | 2019 | 33 | 0.140 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 412 | 0.140 |
Why?
|
Hemostatics | 1 | 2014 | 21 | 0.140 |
Why?
|
Genetic Vectors | 3 | 1984 | 671 | 0.140 |
Why?
|
Lung Neoplasms | 1 | 2018 | 393 | 0.140 |
Why?
|
Immunity, Active | 1 | 2013 | 14 | 0.140 |
Why?
|
NF-kappa B | 2 | 2014 | 411 | 0.140 |
Why?
|
Immunization | 3 | 2020 | 119 | 0.130 |
Why?
|
Epitopes | 1 | 2015 | 286 | 0.130 |
Why?
|
Drosophila melanogaster | 1 | 2018 | 471 | 0.130 |
Why?
|
Cell Line | 1 | 2018 | 1959 | 0.130 |
Why?
|
Male | 15 | 2021 | 22944 | 0.130 |
Why?
|
Bone Marrow Cells | 1 | 2014 | 225 | 0.130 |
Why?
|
Nerve Tissue Proteins | 2 | 2014 | 382 | 0.130 |
Why?
|
Th1 Cells | 3 | 2018 | 166 | 0.120 |
Why?
|
Nuclear Proteins | 1 | 2018 | 804 | 0.120 |
Why?
|
Peritonitis | 1 | 1992 | 29 | 0.120 |
Why?
|
Drosophila Proteins | 1 | 2018 | 694 | 0.120 |
Why?
|
Properdin | 1 | 2011 | 11 | 0.120 |
Why?
|
Complement Pathway, Alternative | 1 | 2011 | 24 | 0.110 |
Why?
|
Inflammation | 2 | 2009 | 962 | 0.110 |
Why?
|
Female | 11 | 2021 | 25928 | 0.110 |
Why?
|
Complement Activation | 1 | 2011 | 50 | 0.110 |
Why?
|
Signal Transduction | 3 | 2020 | 2741 | 0.110 |
Why?
|
Phagocytes | 1 | 2011 | 49 | 0.110 |
Why?
|
Rats | 4 | 2021 | 1806 | 0.110 |
Why?
|
Cell Proliferation | 1 | 2015 | 881 | 0.110 |
Why?
|
Polysaccharides | 1 | 2011 | 123 | 0.100 |
Why?
|
Mice, Transgenic | 3 | 2018 | 1136 | 0.100 |
Why?
|
Antibodies, Monoclonal | 2 | 2004 | 802 | 0.100 |
Why?
|
Granulocytes | 2 | 2003 | 59 | 0.100 |
Why?
|
Intestinal Diseases, Parasitic | 2 | 2019 | 28 | 0.090 |
Why?
|
Cricetinae | 2 | 2021 | 386 | 0.090 |
Why?
|
Mice, Knockout | 4 | 2018 | 1940 | 0.090 |
Why?
|
Porosity | 1 | 2008 | 29 | 0.090 |
Why?
|
NIH 3T3 Cells | 1 | 2008 | 96 | 0.090 |
Why?
|
Fluorescence | 1 | 2008 | 84 | 0.090 |
Why?
|
RNA, Transfer | 1 | 2008 | 68 | 0.090 |
Why?
|
Phagocytosis | 3 | 2020 | 222 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 759 | 0.080 |
Why?
|
Interferon-gamma | 2 | 2020 | 557 | 0.080 |
Why?
|
Survival Analysis | 2 | 2018 | 483 | 0.080 |
Why?
|
Toll-Like Receptors | 1 | 2009 | 439 | 0.080 |
Why?
|
Polyethylene Glycols | 1 | 2008 | 156 | 0.080 |
Why?
|
Green Fluorescent Proteins | 1 | 2008 | 335 | 0.080 |
Why?
|
Gene Silencing | 1 | 2009 | 344 | 0.080 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 387 | 0.080 |
Why?
|
Transfection | 1 | 2008 | 644 | 0.080 |
Why?
|
Flow Cytometry | 1 | 2008 | 665 | 0.080 |
Why?
|
HT29 Cells | 2 | 2015 | 21 | 0.070 |
Why?
|
Caco-2 Cells | 2 | 2015 | 58 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 2019 | 408 | 0.070 |
Why?
|
T-Lymphocytes | 2 | 2020 | 926 | 0.070 |
Why?
|
Transformation, Bacterial | 1 | 1983 | 12 | 0.070 |
Why?
|
Trichoderma | 1 | 2003 | 2 | 0.070 |
Why?
|
Hymecromone | 1 | 2003 | 2 | 0.070 |
Why?
|
Acetylglucosamine | 1 | 2003 | 10 | 0.070 |
Why?
|
Serratia marcescens | 1 | 2003 | 6 | 0.070 |
Why?
|
Chitinases | 1 | 2003 | 10 | 0.070 |
Why?
|
Streptomyces | 1 | 2003 | 13 | 0.070 |
Why?
|
Genotype | 3 | 2017 | 583 | 0.070 |
Why?
|
Biological Warfare | 1 | 2003 | 3 | 0.060 |
Why?
|
Bacillus anthracis | 1 | 2003 | 12 | 0.060 |
Why?
|
Bioterrorism | 1 | 2003 | 14 | 0.060 |
Why?
|
Gene Expression | 2 | 2017 | 785 | 0.060 |
Why?
|
Species Specificity | 2 | 2019 | 322 | 0.060 |
Why?
|
Gingivitis | 1 | 2002 | 7 | 0.060 |
Why?
|
Porphyromonas gingivalis | 1 | 2002 | 22 | 0.060 |
Why?
|
Treatment Outcome | 3 | 2017 | 3763 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 2 | 2021 | 504 | 0.060 |
Why?
|
Mice, Inbred Strains | 2 | 2012 | 170 | 0.060 |
Why?
|
Neutrophil Infiltration | 1 | 2002 | 53 | 0.060 |
Why?
|
Myelin-Oligodendrocyte Glycoprotein | 1 | 2021 | 7 | 0.060 |
Why?
|
Myelin Proteolipid Protein | 1 | 2021 | 7 | 0.060 |
Why?
|
Freund's Adjuvant | 1 | 2021 | 11 | 0.060 |
Why?
|
Immunotherapy | 1 | 2003 | 194 | 0.060 |
Why?
|
Lymphoid Tissue | 2 | 2015 | 57 | 0.060 |
Why?
|
Bacterial Infections | 1 | 2002 | 118 | 0.060 |
Why?
|
Goats | 1 | 2020 | 13 | 0.060 |
Why?
|
Parasite Egg Count | 1 | 2020 | 16 | 0.060 |
Why?
|
Survival Rate | 1 | 2003 | 658 | 0.050 |
Why?
|
Feces | 1 | 2020 | 92 | 0.050 |
Why?
|
Sheep | 1 | 2020 | 156 | 0.050 |
Why?
|
Administration, Oral | 2 | 2013 | 299 | 0.050 |
Why?
|
Interleukin-1beta | 2 | 2014 | 245 | 0.050 |
Why?
|
Ivermectin | 1 | 2019 | 9 | 0.050 |
Why?
|
Cattle | 1 | 2020 | 300 | 0.050 |
Why?
|
Receptors, CXCR3 | 1 | 2020 | 28 | 0.050 |
Why?
|
Zymosan | 2 | 2011 | 23 | 0.050 |
Why?
|
Respiratory Mucosa | 1 | 2020 | 37 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2021 | 333 | 0.050 |
Why?
|
Immunophenotyping | 1 | 2020 | 202 | 0.050 |
Why?
|
Avena | 1 | 1999 | 3 | 0.050 |
Why?
|
Larva | 1 | 2019 | 161 | 0.050 |
Why?
|
Mesocricetus | 1 | 2019 | 99 | 0.050 |
Why?
|
HLA-DR4 Antigen | 1 | 2018 | 9 | 0.050 |
Why?
|
Rats, Inbred F344 | 1 | 2018 | 55 | 0.050 |
Why?
|
Vaccines, Attenuated | 1 | 2018 | 39 | 0.050 |
Why?
|
Coculture Techniques | 1 | 2018 | 87 | 0.050 |
Why?
|
Antigens, Protozoan | 1 | 2018 | 39 | 0.050 |
Why?
|
Necatoriasis | 1 | 2018 | 3 | 0.050 |
Why?
|
Necator americanus | 1 | 2018 | 3 | 0.050 |
Why?
|
Intestinal Absorption | 1 | 2018 | 32 | 0.050 |
Why?
|
Dietary Fiber | 1 | 1999 | 84 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2021 | 761 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2018 | 74 | 0.040 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 409 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2003 | 569 | 0.040 |
Why?
|
Sirolimus | 1 | 2017 | 62 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2018 | 89 | 0.040 |
Why?
|
Adaptation, Physiological | 1 | 2018 | 90 | 0.040 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2018 | 240 | 0.040 |
Why?
|
Dogs | 1 | 2018 | 284 | 0.040 |
Why?
|
Digestion | 1 | 2018 | 117 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2018 | 491 | 0.040 |
Why?
|
Lipids | 1 | 1999 | 292 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 225 | 0.040 |
Why?
|
Psoriasis | 2 | 1973 | 44 | 0.040 |
Why?
|
Oligosaccharides | 2 | 2003 | 57 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2018 | 228 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2015 | 73 | 0.040 |
Why?
|
Chromatography, Gel | 1 | 2015 | 68 | 0.040 |
Why?
|
Substrate Specificity | 2 | 2009 | 314 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 96 | 0.040 |
Why?
|
Alleles | 1 | 2017 | 397 | 0.040 |
Why?
|
Phosphorylation | 1 | 2018 | 819 | 0.040 |
Why?
|
Mutation | 1 | 1983 | 2215 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 1574 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 109 | 0.040 |
Why?
|
Alveolar Bone Loss | 1 | 1995 | 2 | 0.040 |
Why?
|
Biomarkers | 1 | 2020 | 944 | 0.040 |
Why?
|
Neoplasms | 1 | 2004 | 958 | 0.040 |
Why?
|
Microscopy, Electron | 1 | 2015 | 247 | 0.040 |
Why?
|
Neutrophil Activation | 1 | 1995 | 25 | 0.040 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 218 | 0.040 |
Why?
|
Immunoconjugates | 1 | 2014 | 50 | 0.040 |
Why?
|
U937 Cells | 1 | 2014 | 10 | 0.030 |
Why?
|
Macrophage-1 Antigen | 2 | 2004 | 30 | 0.030 |
Why?
|
Vaccines, Live, Unattenuated | 1 | 2013 | 2 | 0.030 |
Why?
|
Polyglycolic Acid | 1 | 2014 | 16 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 532 | 0.030 |
Why?
|
Lactic Acid | 1 | 2014 | 60 | 0.030 |
Why?
|
Protein Binding | 1 | 2018 | 1525 | 0.030 |
Why?
|
Cell Survival | 1 | 2015 | 529 | 0.030 |
Why?
|
Genes, Bacterial | 2 | 1984 | 131 | 0.030 |
Why?
|
RNA Interference | 1 | 2017 | 596 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 189 | 0.030 |
Why?
|
Immunoglobulin A | 1 | 2013 | 72 | 0.030 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2014 | 216 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 1992 | 22 | 0.030 |
Why?
|
Antibodies, Blocking | 1 | 2012 | 40 | 0.030 |
Why?
|
Immunoblotting | 1 | 2012 | 185 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2018 | 1240 | 0.030 |
Why?
|
Leukocyte Count | 1 | 1992 | 92 | 0.030 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 159 | 0.030 |
Why?
|
Child | 1 | 2021 | 3566 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 1992 | 68 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 1992 | 140 | 0.030 |
Why?
|
Cohort Studies | 1 | 2017 | 2022 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 432 | 0.030 |
Why?
|
3T3-L1 Cells | 1 | 2011 | 83 | 0.030 |
Why?
|
COS Cells | 1 | 2011 | 178 | 0.030 |
Why?
|
Base Sequence | 2 | 1984 | 1294 | 0.030 |
Why?
|
Ligands | 1 | 2012 | 401 | 0.030 |
Why?
|
Bacteria | 1 | 1973 | 229 | 0.030 |
Why?
|
Inflammasomes | 1 | 2014 | 272 | 0.030 |
Why?
|
Phenotype | 2 | 1984 | 1003 | 0.030 |
Why?
|
Particle Size | 1 | 2011 | 364 | 0.020 |
Why?
|
Uridine Diphosphate Glucuronic Acid | 1 | 1989 | 3 | 0.020 |
Why?
|
Uridine Diphosphate Sugars | 1 | 1989 | 3 | 0.020 |
Why?
|
Lactose | 1 | 1989 | 12 | 0.020 |
Why?
|
Cytidine Monophosphate N-Acetylneuraminic Acid | 1 | 1989 | 12 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2014 | 678 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 116 | 0.020 |
Why?
|
Organ Specificity | 1 | 2009 | 172 | 0.020 |
Why?
|
Adult | 2 | 2017 | 13041 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 119 | 0.020 |
Why?
|
Sialic Acids | 1 | 1989 | 45 | 0.020 |
Why?
|
Hyaluronic Acid | 1 | 1989 | 41 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2009 | 346 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2014 | 708 | 0.020 |
Why?
|
Down-Regulation | 1 | 2009 | 290 | 0.020 |
Why?
|
Up-Regulation | 1 | 2009 | 373 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2009 | 190 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 1547 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 539 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2009 | 623 | 0.020 |
Why?
|
Fusaric Acid | 1 | 1984 | 1 | 0.020 |
Why?
|
Chimera | 1 | 1984 | 39 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 1984 | 58 | 0.020 |
Why?
|
Complement C3b | 1 | 2003 | 17 | 0.020 |
Why?
|
Brachyura | 1 | 2003 | 1 | 0.020 |
Why?
|
DNA Restriction Enzymes | 1 | 1984 | 34 | 0.020 |
Why?
|
Complex Mixtures | 1 | 2003 | 5 | 0.020 |
Why?
|
Disaccharides | 1 | 2003 | 11 | 0.020 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2003 | 14 | 0.020 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2003 | 12 | 0.020 |
Why?
|
Chromatography, Thin Layer | 1 | 2003 | 15 | 0.020 |
Why?
|
Trisaccharides | 1 | 2003 | 10 | 0.020 |
Why?
|
Glucosamine | 1 | 2003 | 9 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1983 | 97 | 0.020 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2003 | 51 | 0.020 |
Why?
|
Colloids | 1 | 2003 | 43 | 0.020 |
Why?
|
Hydrolysis | 1 | 2003 | 132 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2009 | 773 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2003 | 178 | 0.020 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2002 | 45 | 0.020 |
Why?
|
Aged | 1 | 2017 | 10739 | 0.020 |
Why?
|
Models, Animal | 1 | 2002 | 200 | 0.010 |
Why?
|
Kinetics | 1 | 2003 | 725 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2002 | 554 | 0.010 |
Why?
|
Middle Aged | 1 | 2017 | 13396 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2003 | 320 | 0.010 |
Why?
|
Neutrophils | 1 | 2002 | 341 | 0.010 |
Why?
|
Carbohydrate Conformation | 1 | 1999 | 15 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 1999 | 72 | 0.010 |
Why?
|
History, 20th Century | 1 | 1999 | 215 | 0.010 |
Why?
|
Cholesterol | 1 | 1999 | 270 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 1999 | 381 | 0.010 |
Why?
|
Polymers | 1 | 1958 | 262 | 0.010 |
Why?
|
Dental Pulp Necrosis | 1 | 1995 | 1 | 0.010 |
Why?
|
Bacteria, Anaerobic | 1 | 1995 | 5 | 0.010 |
Why?
|
Peptides | 1 | 1958 | 498 | 0.010 |
Why?
|
Time Factors | 1 | 2002 | 3166 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1995 | 85 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1995 | 399 | 0.010 |
Why?
|
Regression Analysis | 1 | 1995 | 468 | 0.010 |
Why?
|
Sterilization | 1 | 1972 | 14 | 0.010 |
Why?
|
Wound Healing | 1 | 1972 | 150 | 0.010 |
Why?
|
Skin | 1 | 1972 | 295 | 0.010 |
Why?
|
Cytidine Triphosphate | 1 | 1989 | 1 | 0.010 |
Why?
|
Clostridium perfringens | 1 | 1989 | 3 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 1989 | 46 | 0.010 |
Why?
|
Neuraminidase | 1 | 1989 | 51 | 0.010 |
Why?
|
N-Acetylneuraminic Acid | 1 | 1989 | 46 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1989 | 241 | 0.010 |
Why?
|
Cytochrome Reductases | 1 | 1960 | 3 | 0.000 |
Why?
|
Oxidoreductases | 1 | 1960 | 53 | 0.000 |
Why?
|
Oxidation-Reduction | 1 | 1960 | 286 | 0.000 |
Why?
|
Viruses | 1 | 1960 | 76 | 0.000 |
Why?
|
Colitis, Ulcerative | 1 | 1960 | 51 | 0.000 |
Why?
|
Colitis | 1 | 1960 | 75 | 0.000 |
Why?
|
Fatty Acids | 1 | 1960 | 172 | 0.000 |
Why?
|
Hodgkin Disease | 1 | 1956 | 53 | 0.000 |
Why?
|
Immunity | 1 | 1956 | 98 | 0.000 |
Why?
|
Surgical Wound Infection | 1 | 1972 | 73 | 0.000 |
Why?
|
Staphylococcal Infections | 1 | 1972 | 97 | 0.000 |
Why?
|